Today is the final installment of our three-part investigation into the coronavirus’ ultimate impact on the drug channel.
Below, I examine expectations about how the coronavirus will affect the public’s perception of various industry participants. We explore what our survey respondents said about:
- Pharmacies
- Pharmaceutical manufacturers
- Hospitals
- Wholesalers
- Pharmacy benefit managers and plan sponsors
- Insurance companies.
In these early stages of this crisis, my crystal ball is as cloudy as yours. Let’s hope that the country will stabilize within a few months. I may then rerun the survey to determine how (if at all) everyone’s perspective has changed.
Read more »
Source: Post feed
